Characteristics, therapeutic pathway and the economic burden of patients with drug-resistant epilepsy: A real-world analysis following the introduction of cenobamate in Italy.
Perrone V, Veronesi C, Cappuccilli M, Andretta M, Bacca M, Barbieri A, Bartolini F, Brega A, Cillo MR, Colasuonno F, Dell'Orco S, Ferrante F, Grego S, Lavalle A, Mancini D, Pastorello M, Pagliaro R, Procacci C, Scandolara C, Schiavone P, Ubertazzo L, Valpondi P, Vercellone A, Zucchi A, Ciappetta M, Lucatelli D, Cinti Luciani A, Degli Esposti L.
Perrone V, et al.
Epilepsia. 2026 Feb;67(2):620-633. doi: 10.1111/epi.18673. Epub 2025 Oct 24.
Epilepsia. 2026.
PMID: 41134104
Free PMC article.